BSE Live
Mar 06, 09:09Prev. Close
2225.45
Open Price
2248.55
Bid Price (Qty.)
2225.45 (6)
Offer Price (Qty.)
2249.00 (25)
NSE Live
Mar 06, 09:07Prev. Close
2226.40
Open Price
2231.70
Bid Price (Qty.)
2449.00 (40)
Offer Price (Qty.)
2058.50 (107)
| Cash Flow of Mankind Pharma (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | Mar 12 | Mar 10 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 558.31 | 485.58 | 396.45 | 278.23 | 249.46 | |
| Net CashFlow From Operating Activities | 956.75 | 355.00 | 302.53 | -12.85 | 134.50 | |
| Net Cash Used In Investing Activities | -44.62 | -358.15 | -285.77 | 20.74 | -84.29 | |
| Net Cash Used From Financing Activities | -107.58 | -1.41 | -1.40 | -2.15 | -10.27 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 804.56 | -4.55 | 15.36 | 5.74 | 39.94 | |
| Cash And Cash Equivalents Begin of Year | -777.82 | 104.51 | 89.15 | 83.41 | 59.61 | |
| Cash And Cash Equivalents End Of Year | 26.73 | 99.96 | 104.51 | 89.15 | 99.55 |
17.02.2026
05.02.2026
Mankind Pharma Consolidated December 2025 Net Sales at Rs 3,567.20 crore, up 10.44% Y-o-Y
05.02.2026
Mankind Pharma Standalone December 2025 Net Sales at Rs 2,632.68 crore, up 9.85% Y-o-Y
04.02.2026
05.02.2026
Mankind Pharma Consolidated December 2025 Net Sales at Rs 3,567.20 crore, up 10.44% Y-o-Y
05.02.2026
Mankind Pharma Standalone December 2025 Net Sales at Rs 2,632.68 crore, up 9.85% Y-o-Y
12.11.2025
Mankind Pharma Standalone September 2025 Net Sales at Rs 2,608.78 crore, up 3.12% Y-o-Y
07.11.2025
Mankind Pharma Consolidated September 2025 Net Sales at Rs 3,697.16 crore, up 20.17% Y-o-Y